Seven awards funded:

  • Biomaterial-Based Delivery of Immunosuppressive Dendritic Cells for Enhanced Longevity of Murine Allogeneic Islet Transplants
    • Julia Babensee, PhD, Associate Professor, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology ($75,000)
  • Pre-Investigative New Drug (IND) Delivery Testing of Autologous MSCs in Plasma Gel Vehicle in a Porcine Model of Critical Limb Ischemia
    • Luke Brewster, MD, PhD, Assistant Professor, Emory University School of Medicine Surgery ($75,000)
  • Biofunctionalized Hydrogels for Intestinal Epithelial Stem Cell Delivery
    • Andres Garcia, PhD, Regents Professor, Georgia Institute of Technology College of Engineering Mechanical Engineering ($75,000)
  • Biomaterial-Based Synthetic Lymphoid-Tissue Niches for Generation of Antigen-Specific Memory B Cells and Plasma Cells from Stem Cells: Towards On-Demand B Cell Immunotherapy
    • Krishnendu Roy, PhD, Professor, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology ($75,000)
  • Development of a Tissue Engineered Implant for Pelvic Organ Prolapse Repair
    • Stacey Schutte, PhD, Instructor, Emory University School of Medicine Gynecology & Obstetrics ($74,087)
  • Longitudinal MRI and MRS Assessment of iPSC Neural Stem Cell Treatment in White Brain Matter
    • Franklin West, PhD, Assistant Professor, University of Georgia School of Agriculture & Environmental Science Animal & Dairy Science ($70,000)
  • MRI-Guided Robotic Targeting System for Cellular Therapeutic Injections in the Human Spinal Cord
    • John Oshinski, PhD, Associate Professor, Emory University School of Medicine Radiology ($69,826)

Upcoming Events

    View All Events

    Funding News


    Georgia CTSA Request for Community Grant Writing Academy Applicants-Due Thursday

    Georgia CTSA’s Community Engagement program is soliciting proposals to support community-based organization’s seeking to gain capacities in the development of grant proposals to fund research or other health initiatives...


    CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

    A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....